力宝(00226) - 2024 - 中期财报

Financial Performance - Revenue for the six months ended June 30, 2024, was HKD 410,008,000, an increase of 6.5% compared to HKD 386,902,000 in 2023[4] - Total profit for the period was HKD 266,153,000, up from HKD 232,056,000 in the previous year, representing a growth of 14.7%[4] - The company reported a loss before tax of HKD 589,718,000, compared to a loss of HKD 4,220,000 in 2023, indicating a significant decline[4] - The net loss for the period was HKD 594,847,000, compared to a loss of HKD 8,214,000 in the same period last year[5] - The company reported a pre-tax loss of HKD 51,822,000 for the six months ended June 30, 2024, compared to a pre-tax profit of HKD 28,927,000 for the same period in 2023[40] - The company reported a consolidated loss attributable to shareholders of HKD 437 million for the six months ended June 30, 2024, compared to a profit of HKD 3 million for the same period in 2023[83] Assets and Liabilities - The company's total assets decreased to HKD 13,177,521,000 from HKD 14,091,684,000, reflecting a decline of 6.5%[7] - Non-current assets amounted to HKD 12,842,119,000, down from HKD 14,343,414,000, a decrease of 10.5%[8] - The company’s total cash and cash equivalents at the end of the period stood at HK$435,647,000, down from HK$823,987,000 a year earlier[12] - Total liabilities as of June 30, 2024, were HKD 2,220,208,000, a slight increase from HKD 2,220,208,000 as of December 31, 2023[28] - The company's total bank loans amounted to HKD 1,740,447,000, an increase of 6.1% from HKD 1,640,297,000 as of December 31, 2023[53] - The equity attributable to the company's shareholders decreased to HKD 8.3 billion as of June 30, 2024, from HKD 9.1 billion as of December 31, 2023[103] Cash Flow - For the six months ended June 30, 2024, the company reported a cash flow from operating activities of (HK$6,933,000), a significant decrease compared to HK$348,000 in the same period of 2023[12] - Cash flow from financing activities showed an inflow of HK$5,466,000, contrasting with an outflow of (HK$39,020,000) in the same period last year[12] - The total cash and cash equivalents decreased by HK$15,841,000, compared to a decrease of HK$39,943,000 in the prior year[12] Segment Performance - The property investment segment generated a profit of HKD 42,962 million, while the property development segment reported a loss of HKD 3,414 million[24] - The food business segment achieved a revenue of HKD 347,617 million, reflecting a stable performance compared to the previous year[24] - The healthcare services segment did not report any revenue, indicating a focus on management services rather than direct sales[24] - The financial investment segment recorded a profit of HKD 3,544 million, and the securities investment segment reported a loss of HKD 45,737 million[24] Financing Costs - The company incurred financing costs of HKD 57,176,000, an increase from HKD 50,775,000 in 2023[4] - The company paid HK$54,347,000 in financing costs during the period, compared to HK$47,948,000 in the previous year[12] - The company incurred a total financing cost of HKD 19,216 million, which includes interest expenses across various segments[24] Shareholder Information - The company announced that no interim dividend will be paid for the six months ended June 30, 2024, consistent with the previous year[49] - The company's equity attributable to shareholders per share was calculated based on an average of approximately 493,154,000 ordinary shares for both 2024 and 2023[45] - The board has approved a dividend payout of HKD 0.50 per share, reflecting a commitment to returning value to shareholders[134] Corporate Governance - The company emphasizes its commitment to high-quality corporate governance practices to enhance investor confidence[130] - The audit committee has reviewed the accounting principles and practices adopted by the group for the interim financial report[129] - The company has complied with the corporate governance code provisions as of June 30, 2024[130] Market Outlook and Strategy - The company plans to expand its market presence in Singapore and Malaysia, with revenue from Singapore reaching HKD 221,151,000 for the six months ended June 30, 2024[33] - The company has identified new strategies for product development and market expansion, focusing on enhancing service offerings in the food sector[33] - The group anticipates stable global growth for the year, with Singapore's GDP growth forecast narrowed to between 2.0% and 3.0% for 2024[107] Employee Costs - Employee costs rose to HKD 163,518,000 in 2024, up from HKD 149,642,000 in 2023, indicating a 9.3% increase year-over-year[40] - The group employed 856 full-time employees as of June 30, 2024, an increase from 786 full-time employees a year earlier[106] Investment and Fair Value - The fair value of the company's equity interest in Healthway is HKD 475,000,000 as of June 30, 2024, down from HKD 489,000,000 as of December 31, 2023[100] - The fair value of financial assets measured at fair value through profit or loss was HKD 621,450,000 as of June 30, 2024, compared to HKD 752,346,000 as of December 31, 2023, indicating a decline of about 17.4%[67] - The company recorded an unrealized fair value loss of HKD 9,000,000 during the period, with the total fair value of financial assets measured at fair value amounting to HKD 621,450,000[96]